Van Hoef Consulting provides services to biopharma and biotech companies in clinical development and medical affairs including pharmacovigilance and regulatory. Specialized in oncology, hematology and cell therapy.
Phases of development: phase I-IV, observational studies.
Services for biologics, targeted and immune therapies, cell therapy and drugs including small molecules. Detailed services upon request.
M Van Hoef worked in industry, at a CRO, Swissmedic in market authorization, registries, as consultant.